Indiana University Melvin & Bren Simon Cancer Center — Indianapolis, Indiana

Indiana University Melvin & Bren Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana University Melvin & Bren Simon Cancer Center has participated in 27 clinical trials with 6 currently active.

Therapeutic areas: Advanced Cancer, Metastatic Cancer, Solid Tumor.

Sponsors: Indiana University, Naoyuki G. Saito, M.D., Ph.D., Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Melvin & Bren Simon Cancer Center?

Indiana University Melvin & Bren Simon Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Melvin & Bren Simon Cancer Center conducted?

Indiana University Melvin & Bren Simon Cancer Center has 27 clinical trials on record, with 6 currently active. Their work covers Advanced Cancer, Metastatic Cancer, Solid Tumor.

Is Indiana University Melvin & Bren Simon Cancer Center accredited by Crixeo Health?

Yes — Indiana University Melvin & Bren Simon Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana University Melvin & Bren Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.